BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29641956)

  • 1. Finding a Treatment for ALS - Will Gene Editing Cut It?
    Al-Chalabi A; Brown RH
    N Engl J Med; 2018 Apr; 378(15):1454-1456. PubMed ID: 29641956
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo genome editing improves motor function and extends survival in a mouse model of ALS.
    Gaj T; Ojala DS; Ekman FK; Byrne LC; Limsirichai P; Schaffer DV
    Sci Adv; 2017 Dec; 3(12):eaar3952. PubMed ID: 29279867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene therapy of ALS with RNA interference].
    Yokota T
    Rinsho Shinkeigaku; 2009 Nov; 49(11):821-3. PubMed ID: 20030220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Duan W; Guo M; Yi L; Liu Y; Li Z; Ma Y; Zhang G; Liu Y; Bu H; Song X; Li C
    Gene Ther; 2020 Apr; 27(3-4):157-169. PubMed ID: 31819203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi therapy: dominant disease gene gets silenced.
    Xu Z; Xia XG
    Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
    [No Abstract]   [Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis and gene therapy.
    Miller TM; Smith RA; Cleveland DW
    Nat Clin Pract Neurol; 2006 Sep; 2(9):462-3. PubMed ID: 16932606
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV6-mediated gene silencing fALS short.
    Mandel RJ; Lowenstein PR; Byrne BJ
    Mol Ther; 2011 Feb; 19(2):231-3. PubMed ID: 21289637
    [No Abstract]   [Full Text] [Related]  

  • 9. The tsunami named CRISPR/Cas9.
    Chneiweiss H
    Rev Neurol (Paris); 2018; 174(7-8):487-488. PubMed ID: 29779853
    [No Abstract]   [Full Text] [Related]  

  • 10. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
    Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
    Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference protects against ALS in mouse model.
    Burton A
    Lancet Neurol; 2005 May; 4(5):274-5. PubMed ID: 15861555
    [No Abstract]   [Full Text] [Related]  

  • 12. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.
    Nizzardo M; Simone C; Falcone M; Riboldi G; Rizzo F; Magri F; Bresolin N; Comi GP; Corti S
    Cell Mol Life Sci; 2012 May; 69(10):1641-50. PubMed ID: 22094924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Editing for Amyotrophic Lateral Sclerosis: Leading Off First Base.
    Cunningham TJ; Fisher E; Fratta P; Gilthorpe JD
    CRISPR J; 2020 Apr; 3(2):75-77. PubMed ID: 32315228
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene therapy for ALS delivers.
    Boillée S; Cleveland DW
    Trends Neurosci; 2004 May; 27(5):235-8. PubMed ID: 15111001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kostic V; Jackson-Lewis V; de Bilbao F; Dubois-Dauphin M; Przedborski S
    Science; 1997 Jul; 277(5325):559-62. PubMed ID: 9228005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has gene therapy for ALS arrived?
    Miller TM; Cleveland DW
    Nat Med; 2003 Oct; 9(10):1256-7. PubMed ID: 14520369
    [No Abstract]   [Full Text] [Related]  

  • 17. RNA interference and amyotrophic lateral sclerosis.
    Rizvanov AA; Gulluoglu S; Yalvaç ME; Palotás A; Islamov RR
    Curr Drug Metab; 2011 Sep; 12(7):679-83. PubMed ID: 21740381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.
    Miller TM; Kaspar BK; Kops GJ; Yamanaka K; Christian LJ; Gage FH; Cleveland DW
    Ann Neurol; 2005 May; 57(5):773-6. PubMed ID: 15852369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates.
    Borel F; Gernoux G; Cardozo B; Metterville JP; Toro Cabrera GC; Song L; Su Q; Gao GP; Elmallah MK; Brown RH; Mueller C
    Hum Gene Ther; 2016 Jan; 27(1):19-31. PubMed ID: 26710998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene therapy of ALS with short interfering RNA].
    Yokota T
    Brain Nerve; 2007 Oct; 59(10):1187-94. PubMed ID: 17969360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.